Cas No.: | 1253733-17-3 |
Chemical Name: | 2-(4-(2-(isopropylamino)ethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one |
Synonyms: | RVX 2135 |
Formula: | C23H29N3O4 |
M.Wt: | 411.502 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | RVX2135 is a novel potent and orally bioavailable inhibitor of Brd2, Brd3, Brd4, and BrdT with IC50 of 1.31, 0.58, 0.44, and 1.58 uM, respectively; blocks proliferation of Myc-induced mouse lymphoma cells and induces Caspase-dependent apoptosis; exhibits broad transcriptional effects in Myc-transgenic lymphoma cells affecting many transcription factor networks. |